The Role of Metabolites in CSF on NAFLD Development: A Mendelian Randomisation Analysis
Open Access
- 23 November 2025
- journal article
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 8 (6) , e70088
Abstract
Background: Non‐alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition linked to metabolic syndrome. Recent studies suggest that metabolites in cerebrospinal fluid (CSF) may play a role in NAFLD development; however, the specific causal relationship between the two remains unclear. Methods: This bidirectional two‐sample Mendelian randomisation (MR) study analysed the causal relationships between 337 CSF metabolites and NAFLD. We used genome‐wide association study (GWAS) datasets from the OpenGWAS and FinnGen databases. MR analysis was mainly conducted through the inverse‐variance weighted method from the ‘TwoSampleMR’ R package, and sensitivity analyses were conducted to validate findings. Results: A total of 24 CSF metabolites were found to have significant causal relationships with NAFLD, with 13 identified in the discovery group and 13 in the validation group. These metabolites predominantly include amino acids, amino acid derivatives, esters, lipids, lipid derivatives, nucleotides, organic acids, carbohydrates and vitamins. Notably, metabolites of lipid derivatives such as 7‐alpha‐hydroxy‐3‐oxo‐4‐cholestenoate (7‐HOCA) exhibited a consistent positive causal effect on NAFLD, and nucleotide metabolites uracil showed a consistent inverse causal effect on NAFLD both in the discovery and validation groups. Sensitivity analyses showed robust results without significant pleiotropy or heterogeneity. Conclusion: This study reveals significant causal associations between specific CSF metabolites and NAFLD, emphasising the importance of the brain‐liver axis in NAFLD pathogenesis. These findings provide a scientific basis for developing early diagnostic biomarkers and personalised therapeutic strategies targeting CSF metabolites, potentially improving NAFLD management and patient outcomes.Keywords
This publication has 85 references indexed in Scilit:
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndromeThe Lancet Diabetes & Endocrinology, 2014
- Biomarkers of Coordinate Metabolic Reprogramming in Colorectal Tumors in Mice and HumansGastroenterology, 2014
- 7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrierJournal of Lipid Research, 2014
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Proprotein convertases in high-density lipoprotein metabolismBiomarker Research, 2013
- Cholesterol metabolism in neurons and astrocytesProgress in Lipid Research, 2011
- Avoiding bias from weak instruments in Mendelian randomization studiesInternational Journal of Epidemiology, 2011
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiologyStatistics in Medicine, 2008
- Uracil‐tegafur as an adjuvant for hepatocellular carcinomaHepatology, 2006
- Central nervous system control of food intakeNature, 2000